EPCAM and breast cancer: Moreover, the presence of EpCAM-/CD49f + cells has recently been shown to increase metastatic potential and to reduce disease-free survival of breast cancer patients [46]; MDA-MB-231 cells are classified as EpCAM−/CD49f + [15].